The Valley Desk

NCT03123783 · Interventional trial

CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab

Overall registry status Completed

Phase 1 · Phase 2

Conditions Cancer, Melanoma, Metastatic Melanoma, Neoplasm of Lung, Non Small Cell Lung Cancer Metastatic

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov